Abstract
The relationship between diabetes mellitus and risk of inappropriate or appropriate therapy in patients receiving an implantable cardioverter-defibrillator (ICD) and resynchronization therapy has not been investigated thoroughly. The effect of innovative ICD programming on therapy delivery in these patients is unknown.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Circulation (Baltimore) |
| Vol/bind | 128 |
| Udgave nummer | 7 |
| Sider (fra-til) | 694-701 |
| Antal sider | 8 |
| ISSN | 0009-7322 |
| DOI | |
| Status | Udgivet - 13 aug. 2013 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS